Roche’s Covid-19 Antibody Test Receives FDA EUA
Roche will ramp up production capacity to high double-digit millions per month to countries accepting the CE mark as well as the United States.
Read MorePosted by | May 4, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Roche will ramp up production capacity to high double-digit millions per month to countries accepting the CE mark as well as the United States.
Read MorePosted by | May 4, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Mass Spectrometry Reagents & Test Kits, Swabs |
AACC has issued a letter to FDA Commissioner Stephen Hahn, MD, in response to the agency’s decision to authorize the first home test collection kit for SARS-CoV-2.
Read MorePosted by | May 1, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The new biosensor is intended for measuring airborne concentrations of the covid-19 virus in real time, in places such as hospitals and train stations.
Read MorePosted by | May 1, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
DiaCarta recently expanded manufacturing capacity to 500,000 tests per week to meet the increasing demand for PCR tests to monitor covid-19.
Read MorePosted by | May 1, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Hemex’s Gazelle platform will enable low-cost covid-19 testing in local health clinics, small labs, doctor’s offices, and field hospitals.
Read More